BackRXO Overview
RXO Inc

RXO Target Price

Analysts' average 12-month price target for RXO is $28.

Get informed when a big investor buys or sells

+ Follow

Share Price

$19.88

Average Target Price

$28.4042.9% upside

10 analysts in the last 4 months

High: $35 | Low: $23

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-09Wells Fargo$2315.7% upsideOpen
2026-08-07Truist Financial$2840.8% upsideOpen
2026-08-07Stifel NicolausBruce Chan$3155.9% upsideOpen
2026-08-07UBS$2315.7% upsideOpen
2026-08-07Deutsche Bank$3050.9% upsideOpen
2026-08-07William Blair$3050.9% upsideOpen
2026-07-13BMO CapitalFadi Chamoun$3576.1% upsideOpen
2026-07-13Stifel NicolausBruce Chan$3050.9% upsideOpen
2026-06-30UBS$2630.8% upsideOpen
2026-06-25Barclays$2840.8% upsideOpen
2026-05-15Stifel Nicolaus$2210.7% upsideOpen
2026-05-08SusquehannaHarrison Bauer$189.5% downsideOpen
2026-05-08Truist FinancialLucas Servera$2630.8% upsideOpen
2026-05-08Goldman Sachs$189.5% downsideOpen
2026-05-08Barclays$200.6% upsideOpen
2026-05-08Wells Fargo$2210.7% upsideOpen
2026-05-07Morgan Stanley$2210.7% upsideOpen
2026-02-09Stephens$1524.5% downsideOpen
2026-02-09Truist FinancialLucas Servera$200.6% upsideOpen
2026-02-05Stifel Nicolaus$1524.5% downsideOpen
2026-01-15Truist FinancialLucas Servera$189.5% downsideOpen
2026-01-08Susquehanna$1144.7% downsideOpen
2025-12-16Stifel Nicolaus$1619.5% downsideOpen
2025-11-11Morgan StanleyRavi Shanker$194.4% downsideOpen
2025-10-14Truist Financial$2210.7% upsideOpen
2025-10-10Stifel NicolausBruce Chan$1714.5% downsideOpen
2025-10-03UBS$1714.5% downsideOpen
2025-06-24Susquehanna$1239.6% downsideOpen
2025-04-24Truist FinancialLucas Servera$194.4% downsideOpen
2025-03-07Deutsche Bank$194.4% downsideOpen
2025-01-07Wells FargoChristian Wetherbee$2840.8% upsideOpen
2024-11-18Goldman SachsJordan Alliger$2945.9% upsideOpen
2024-10-08CitigroupAriel Rosa$3366% upsideOpen
2024-09-26SusquehannaBascome Majors$1619.5% downsideOpen
2024-09-17OppenheimerScott Schneeberger$3155.9% upsideOpen
2024-09-11JefferiesStephanie Moore$3155.9% upsideOpen
2024-07-08StephensDaniel Imbro$2525.8% upsideOpen
2024-06-25Stifel NicolausBruce Chen$2630.8% upsideOpen
2024-06-24JefferiesStephanie Moore$3050.9% upsideOpen
2024-06-20UBSTom Wadewitz$2210.7% upsideOpen
2024-04-11Wolfe ResearchScott Group$1524.5% downsideOpen
2023-06-09SusquehannaBascome Majors$200.6% upsideOpen
2022-12-20Wells Fargo$189.5% downsideOpen
2022-12-09Morgan Stanley$200.6% upsideOpen
2022-12-06Jefferies$2525.8% upsideOpen

RXO (RXO) FAQ

The latest target price for RXO is $28. Investors often review this figure alongside RXO's historical trend and sector peers before judging valuation or financial health.

RXO trades near $19.88 while the consensus target sits at $28 (42.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting RXO's target price ($28), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.